• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和验证与胃癌发病机制和预后相关的关键基因。

Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer.

机构信息

Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

出版信息

PeerJ. 2023 Oct 16;11:e16243. doi: 10.7717/peerj.16243. eCollection 2023.

DOI:10.7717/peerj.16243
PMID:37868053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10586292/
Abstract

BACKGROUND

Gastric cancer (GC) is the fourth leading cause of cancer-related death worldwide. However, the precise mechanisms and specific biomarkers of GC have not been fully elucidated. We therefore sought to identify and validate the genes associated with GC.

METHODS

RNA sequencing was performed on gastric tissue specimens from 10 cases each of non-atrophic gastritis (NAG), intestinal metaplasia (IM), and GC. Validation of gene expression was conducted through immunohistochemistry (IHC) staining. The Kaplan-Meier Plotter database was utilized to screen genes associated with prognosis, while protein-protein interaction analysis was conducted to identify hub genes.

RESULTS

In GC-IM, the differentially expressed genes (DEGs) were predominantly enriched in pathways related to ECM-receptor interaction, focal adhesion, PI3K-Akt pathway, and pathways in cancer. Conversely, in IM-NAG, the DEGs were primarily enriched in pathways associated with fat digestion and absorption, pancreatic secretion, and retinol metabolism. IHC staining revealed elevated expression levels of KLK7 and KLK10 in GC. Specifically, KLK7 expression was found to be correlated with differentiation ( = 0.025) and depth of invasion ( = 0.007) in GC, while both KLK7 and KLK10 were associated with the overall survival ( < 0.05). Furthermore, a total of ten hub genes from DEGs in GC-NAG (COL6A2, COL1A1, COL4A1, COL1A2, SPARC, COL4A2, FN1, PCOLCE, SERPINH1, LAMB1) and five hub genes in IM-NAG (SI, DPP4, CLCA1, MEP1A, OLFM4) were demonstrated to have a significant correlation with the prognosis of GC.

CONCLUSIONS

The present study successfully identified and validated crucial genes associated with GC, providing valuable insights into the underlying mechanisms of this disease. The findings of this study have the potential to inform clinical practice.

摘要

背景

胃癌(GC)是全球癌症相关死亡的第四大原因。然而,GC 的精确机制和特定生物标志物尚未完全阐明。因此,我们试图确定并验证与 GC 相关的基因。

方法

对 10 例非萎缩性胃炎(NAG)、肠上皮化生(IM)和 GC 的胃组织标本进行 RNA 测序。通过免疫组织化学(IHC)染色验证基因表达。利用 Kaplan-Meier Plotter 数据库筛选与预后相关的基因,通过蛋白质-蛋白质相互作用分析识别枢纽基因。

结果

在 GC-IM 中,差异表达基因(DEGs)主要富集在 ECM-受体相互作用、焦点粘连、PI3K-Akt 通路和癌症通路相关的途径中。相反,在 IM-NAG 中,DEGs 主要富集在与脂肪消化和吸收、胰腺分泌和视黄醇代谢相关的途径中。IHC 染色显示 GC 中 KLK7 和 KLK10 的表达水平升高。具体而言,KLK7 的表达与 GC 的分化(=0.025)和浸润深度(=0.007)相关,而 KLK7 和 KLK10 均与总生存期相关(<0.05)。此外,GC-NAG 中 DEGs 的十个枢纽基因(COL6A2、COL1A1、COL4A1、COL1A2、SPARC、COL4A2、FN1、PCOLCE、SERPINH1、LAMB1)和 IM-NAG 中的五个枢纽基因(SI、DPP4、CLCA1、MEP1A、OLFM4)与 GC 的预后显著相关。

结论

本研究成功鉴定和验证了与 GC 相关的关键基因,为该疾病的潜在机制提供了有价值的见解。本研究的结果有可能为临床实践提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/7a18eef243b2/peerj-11-16243-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/201169735539/peerj-11-16243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/784745ff0235/peerj-11-16243-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/627060db0afc/peerj-11-16243-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/38f6368f0f7c/peerj-11-16243-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/7a18eef243b2/peerj-11-16243-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/201169735539/peerj-11-16243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/784745ff0235/peerj-11-16243-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/627060db0afc/peerj-11-16243-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/38f6368f0f7c/peerj-11-16243-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781c/10586292/7a18eef243b2/peerj-11-16243-g005.jpg

相似文献

1
Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer.鉴定和验证与胃癌发病机制和预后相关的关键基因。
PeerJ. 2023 Oct 16;11:e16243. doi: 10.7717/peerj.16243. eCollection 2023.
2
Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.基于综合生物信息学的中国胃癌人群核心预后相关候选基因的鉴定。
Biomed Res Int. 2020 Dec 11;2020:8859826. doi: 10.1155/2020/8859826. eCollection 2020.
3
Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer.基于三个数据集通过生物信息学分析鉴定胃癌中与生存相关的生物标志物
World J Clin Cases. 2023 Jul 16;11(20):4763-4787. doi: 10.12998/wjcc.v11.i20.4763.
4
Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.加权相关网络分析确定了与胃癌进展和预后相关的纤连蛋白1(FN1)、I型胶原蛋白α1链(COL1A1)和纤溶酶原激活物抑制剂1(SERPINE1)。
Cancer Biomark. 2021;31(1):59-75. doi: 10.3233/CBM-200594.
5
Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.整合生物信息学分析揭示胃癌中新型关键生物标志物和潜在候选小分子药物。
Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28.
6
Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.基于生物信息学分析鉴定与胃癌预后相关的潜在生物标志物。
Med Sci Monit. 2021 Feb 14;27:e929104. doi: 10.12659/MSM.929104.
7
Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.通过综合生物信息学分析鉴定胃癌中的枢纽基因和潜在分子机制
PeerJ. 2018 Jul 2;6:e5180. doi: 10.7717/peerj.5180. eCollection 2018.
8
Identification of key biomarkers and potential signaling pathway associated with poor progression of gastric cancer.与胃癌进展不良相关的关键生物标志物和潜在信号通路的鉴定
Transl Cancer Res. 2020 Sep;9(9):5459-5472. doi: 10.21037/tcr-20-926.
9
GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.GADD45B 调控慢性萎缩性胃炎的癌变过程和胃癌的代谢途径。
Front Endocrinol (Lausanne). 2023 Aug 7;14:1224832. doi: 10.3389/fendo.2023.1224832. eCollection 2023.
10
Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods.利用生物信息学分析方法鉴定胃癌中的关键基因以预测预后
Ann Transl Med. 2020 Jul;8(14):884. doi: 10.21037/atm-20-4427.

引用本文的文献

1
VASN drives gastric tumorigenesis via activation of the COL4A1/PI3K/AKT axis during Helicobacter pylori infection.在幽门螺杆菌感染期间,VASN通过激活COL4A1/PI3K/AKT轴驱动胃癌发生。
Br J Cancer. 2025 Jun 23. doi: 10.1038/s41416-025-03081-7.
2
Revealing Potential Therapeutic Targets in Gastric Cancer through Inflammation and Protein-Protein Interaction Hub Networks.通过炎症和蛋白质-蛋白质相互作用枢纽网络揭示胃癌潜在治疗靶点
J Cancer. 2025 Jun 12;16(8):2720-2736. doi: 10.7150/jca.112218. eCollection 2025.
3
Research progress on the therapeutic effects of effective components of traditional Chinese medicine in the treatment of gastric cancer precursors through modulation of multiple signaling pathways.

本文引用的文献

1
Integrated lipidomics and RNA sequencing analysis reveal novel changes during 3T3-L1 cell adipogenesis.整合脂质组学和 RNA 测序分析揭示 3T3-L1 细胞脂肪生成过程中的新变化。
PeerJ. 2022 May 3;10:e13417. doi: 10.7717/peerj.13417. eCollection 2022.
2
KLK8 promotes the proliferation and metastasis of colorectal cancer via the activation of EMT associated with PAR1.KLK8 通过激活与 PAR1 相关的 EMT 促进结直肠癌的增殖和转移。
Cell Death Dis. 2021 Sep 22;12(10):860. doi: 10.1038/s41419-021-04149-x.
3
LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
中药有效成分通过调控多条信号通路治疗胃癌前体病变的研究进展
Front Oncol. 2025 May 19;15:1555274. doi: 10.3389/fonc.2025.1555274. eCollection 2025.
4
Integration of Gastric Cancer RNA-Seq Datasets Along With PPI Network Suggests That Nonhub Nodes Have the Potential to Become Biomarkers.整合胃癌RNA测序数据集并结合蛋白质-蛋白质相互作用网络表明,非枢纽节点有潜力成为生物标志物。
Cancer Rep (Hoboken). 2025 Jan;8(1):e70126. doi: 10.1002/cnr2.70126.
5
The spatial and cellular portrait of transposable element expression during gastric cancer.胃癌中转座元件表达的空间和细胞特征。
Sci Rep. 2024 Sep 30;14(1):22727. doi: 10.1038/s41598-024-73744-7.
6
Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions.胃癌侵袭的分子洞察——现状与未来方向
Cancers (Basel). 2023 Dec 21;16(1):54. doi: 10.3390/cancers16010054.
LAMB1 与 T 分期相关,提示胃癌预后不良。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211004944. doi: 10.1177/15330338211004944.
4
Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.加权相关网络分析确定了与胃癌进展和预后相关的纤连蛋白1(FN1)、I型胶原蛋白α1链(COL1A1)和纤溶酶原激活物抑制剂1(SERPINE1)。
Cancer Biomark. 2021;31(1):59-75. doi: 10.3233/CBM-200594.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Upregulation of LAMB1 via ERK/c-Jun Axis Promotes Gastric Cancer Growth and Motility.ERK/c-Jun 轴上调 LAMB1 促进胃癌生长和迁移。
Int J Mol Sci. 2021 Jan 10;22(2):626. doi: 10.3390/ijms22020626.
7
PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer.PCOLCE是胃癌中强有力的预后生物标志物且与免疫浸润相关。
Front Mol Biosci. 2020 Dec 18;7:544895. doi: 10.3389/fmolb.2020.544895. eCollection 2020.
8
MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion.MiR-215-5p通过调控细胞外基质-受体相互作用和粘着斑减少结直肠癌实验模型中的肝转移。
Cancers (Basel). 2020 Nov 26;12(12):3518. doi: 10.3390/cancers12123518.
9
Screening and eradication of for gastric cancer prevention: the Taipei global consensus.胃癌预防的筛查和根除:台北全球共识。
Gut. 2020 Dec;69(12):2093-2112. doi: 10.1136/gutjnl-2020-322368. Epub 2020 Oct 1.
10
SPARC-p53: The double agents of cancer.SPARC-p53:癌症的双重代理人。
Adv Cancer Res. 2020;148:171-199. doi: 10.1016/bs.acr.2020.05.004. Epub 2020 Jul 21.